<SEC-DOCUMENT>0001193125-17-211058-index.html : 20170623
<SEC-HEADER>0001193125-17-211058.hdr.sgml : 20170623
<ACCEPTANCE-DATETIME>20170623080136
ACCESSION NUMBER:		0001193125-17-211058
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20170622
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170623
DATE AS OF CHANGE:		20170623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REPLIGEN CORP
		CENTRAL INDEX KEY:			0000730272
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				042729386
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14656
		FILM NUMBER:		17926361

	BUSINESS ADDRESS:	
		STREET 1:		41 SEYON STREET
		STREET 2:		BUILDING 1, SUITE 100
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		7814499560

	MAIL ADDRESS:	
		STREET 1:		41 SEYON STREET
		STREET 2:		BUILDING 1, SUITE 100
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d418192d8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: d418192d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>d418192dex21.htm <DESCRIPTION>EX-2.1 <TEXT> Document 2 - file: d418192dex21.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>d418192dex101.htm <DESCRIPTION>EX-10.1 <TEXT> Document 3 - file: d418192dex101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>d418192dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: d418192dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g418192g0623022729185.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g418192g0623022729185.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g418192g91c74.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g418192g91c74.jpg
</DOCUMENT> </SEC-DOCUMENT>